These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373 [TBL] [Abstract][Full Text] [Related]
5. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. Lee H; Akita RW; Sliwkowski MX; Maihle NJ Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077 [TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line. Fallon KB; Havlioglu N; Hamilton LH; Cheng TP; Carroll SL J Neurooncol; 2004 Feb; 66(3):273-84. PubMed ID: 15015657 [TBL] [Abstract][Full Text] [Related]
7. Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival. Li Y; Tennekoon GI; Birnbaum M; Marchionni MA; Rutkowski JL Mol Cell Neurosci; 2001 Apr; 17(4):761-7. PubMed ID: 11312610 [TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners. Li Z; Mei Y; Liu X; Zhou M Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839 [TBL] [Abstract][Full Text] [Related]
9. Autocrine signaling through Ras regulates cell survival activity in human glioma cells: potential cross-talk between Ras and the phosphatidylinositol 3-kinase-Akt pathway. Sakata K; Kato S; Fox JC; Shigemori M; Morimatsu M J Neuropathol Exp Neurol; 2002 Nov; 61(11):975-83. PubMed ID: 12430714 [TBL] [Abstract][Full Text] [Related]
10. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells. Söderlund K; Pérez-Tenorio G; Stål O Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Motoyama AB; Hynes NE; Lane HA Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928 [TBL] [Abstract][Full Text] [Related]
12. An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival. Zhang K; Wong P; Duan J; Jacobs B; Borden EC; Bedogni B Pigment Cell Melanoma Res; 2013 May; 26(3):408-14. PubMed ID: 23480537 [TBL] [Abstract][Full Text] [Related]
13. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Jackson JG; St Clair P; Sliwkowski MX; Brattain MG Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917 [TBL] [Abstract][Full Text] [Related]
14. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. Kainulainen V; Sundvall M; Määttä JA; Santiestevan E; Klagsbrun M; Elenius K J Biol Chem; 2000 Mar; 275(12):8641-9. PubMed ID: 10722704 [TBL] [Abstract][Full Text] [Related]
15. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma. Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584 [TBL] [Abstract][Full Text] [Related]
16. Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway. Sithanandam G; Smith GT; Masuda A; Takahashi T; Anderson LM; Fornwald LW Carcinogenesis; 2003 Oct; 24(10):1581-92. PubMed ID: 12896906 [TBL] [Abstract][Full Text] [Related]
17. Neuregulin-1 enhances motility and migration of human astrocytic glioma cells. Ritch PA; Carroll SL; Sontheimer H J Biol Chem; 2003 Jun; 278(23):20971-8. PubMed ID: 12600989 [TBL] [Abstract][Full Text] [Related]
18. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Li B; Chang CM; Yuan M; McKenna WG; Shu HK Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544 [TBL] [Abstract][Full Text] [Related]